Idexx Laboratories (IDXX) Cash from Investing Activities (2009 - 2026)

Idexx Laboratories (IDXX) has reported Cash from Investing Activities for 18 consecutive years, with -$33.5 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Cash from Investing Activities fell 13.29% year-over-year to -$33.5 million; the TTM figure through Mar 2026 stood at -$140.2 million (down 8.05% YoY), while the FY2025 annual figure was -$136.2 million, up 34.2% from the prior year.
• Cash from Investing Activities came in at -$33.5 million for Q1 2026 at Idexx Laboratories, down from -$28.1 million in the prior quarter.
• The five-year high for Cash from Investing Activities was -$27.4 million in Q3 2024, with the low at -$106.9 million in Q1 2024.
• Average Cash from Investing Activities over 5 years is -$41.0 million, with a median of -$33.6 million recorded in 2025.
• Across the five-year window, Cash from Investing Activities plunged 170.67% in 2024 and soared 72.31% in 2025, its largest moves.
• Year by year, Cash from Investing Activities stood at -$49.2 million in 2022, then surged by 38.18% to -$30.4 million in 2023, then plunged by 30.91% to -$39.8 million in 2024, then rose by 29.4% to -$28.1 million in 2025, then retreated by 19.25% to -$33.5 million in 2026.
• According to Business Quant data, Cash from Investing Activities over the past three periods registered -$33.5 million, -$28.1 million, and -$44.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.